News

Data Watch: Obstacles to Insurance Coverage of Specific Therapies for Multiple Sclerosis


 

ELSEVIER GLOBAL MEDICAL NEWS

Recommended Reading

No PML Seen With Natalizumab Since Summer '06
MDedge Neurology
Early Interferon Lessened Disability in Multiple Sclerosis
MDedge Neurology
Red Flags in Neurologic Examinations Point to MS
MDedge Neurology
Clinical Trial Digest: Findings from Recently Published Randomized Controlled Trials
MDedge Neurology
Can Neuropsychiatric Symptoms Be Predicted in Patients With MS and Cognitive Impairment?
MDedge Neurology
Challenging the Status Quo in Understanding MS
MDedge Neurology
Do Current Outcome Measures Underestimate the Impact of Multiple Sclerosis?
MDedge Neurology
Reuters Health Information: July 2008
MDedge Neurology
Glatiramer Acetate May Delay Conversion to Clinically Definite MS
MDedge Neurology
Advances in Neurogenetics, Neuromics Aid Understanding of Neurologic Disorders
MDedge Neurology